Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation ; volume:12 ; number:1 ; day:25 ; month:1 ; year:2024 ; pages:1-4 ; date:12.2024
Biomarker Research ; 12, Heft 1 (25.1.2024), 1-4, 12.2024
- Creator
-
Guru Murthy, Guru Subramanian
Zhang, Tao
Bolon, Yung-Tsi
Spellman, Stephen
Dong, Jing
Auer, Paul
Saber, Wael
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40364-023-00550-0
- URN
-
urn:nbn:de:101:1-2024040513062954261292
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Guru Murthy, Guru Subramanian
- Zhang, Tao
- Bolon, Yung-Tsi
- Spellman, Stephen
- Dong, Jing
- Auer, Paul
- Saber, Wael
- SpringerLink (Online service)
Other Objects (12)
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Impending relapse of myelodysplastic syndrome after allogeneic transplant is difficult to diagnose and requires a multi-modal approach
The evolution of preclinical models for myelodysplastic neoplasms
How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms
Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
Nontraumatic acute subdural hematoma associated with the myelodysplastic/myeloproliferative neoplasms
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
Proteomics profile in encapsulated follicular patterned thyroid neoplasms
Sustained disease-free survival achieved with withdrawal of immunosuppression after rapid relapse of myelodysplastic syndrome following myeloablative allogeneic hematopoietic transplantation: a case report
Molecular characterization of patients with chronic myeloid leukemia and myeloproliferative/myelodysplastic neoplasms
Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Impending relapse of myelodysplastic syndrome after allogeneic transplant is difficult to diagnose and requires a multi-modal approach
The evolution of preclinical models for myelodysplastic neoplasms
How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms
Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
Nontraumatic acute subdural hematoma associated with the myelodysplastic/myeloproliferative neoplasms
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
Proteomics profile in encapsulated follicular patterned thyroid neoplasms
Sustained disease-free survival achieved with withdrawal of immunosuppression after rapid relapse of myelodysplastic syndrome following myeloablative allogeneic hematopoietic transplantation: a case report
Molecular characterization of patients with chronic myeloid leukemia and myeloproliferative/myelodysplastic neoplasms
Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Impending relapse of myelodysplastic syndrome after allogeneic transplant is difficult to diagnose and requires a multi-modal approach
The evolution of preclinical models for myelodysplastic neoplasms
How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms
Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
Nontraumatic acute subdural hematoma associated with the myelodysplastic/myeloproliferative neoplasms
Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
Proteomics profile in encapsulated follicular patterned thyroid neoplasms
Sustained disease-free survival achieved with withdrawal of immunosuppression after rapid relapse of myelodysplastic syndrome following myeloablative allogeneic hematopoietic transplantation: a case report
Molecular characterization of patients with chronic myeloid leukemia and myeloproliferative/myelodysplastic neoplasms